Close Menu

NEW YORK – The UK Health and Social Care Secretary announced late on Wednesday a £500 million ($667 million) investment in new SARS-CoV-2 testing technology to increase the country's testing capacity.

The new funding builds on an initiative announced in August by the UK's Department of Health and Social Care (DHSC) to roll out rapid coronavirus tests from DnaNudge and Oxford Nanopore Technologies to hospitals, care homes, and laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.